High-throughput sequencing of natively paired antibody chains provides evidence for original antigenic sin shaping the antibody response to influenza vaccination.

We developed a DNA barcoding method to enable high-throughput sequencing of the cognate heavy- and light-chain pairs of the antibodies expressed by individual B cells. We used this approach to elucidate the plasmablast antibody response to influenza vaccination. We show that >75% of the rationally selected plasmablast antibodies bind and neutralize influenza, and that antibodies from clonal families, defined by sharing both heavy-chain VJ and light-chain VJ sequence usage, do so most effectively. Vaccine-induced heavy-chain VJ regions contained on average >20 nucleotide mutations as compared to their predicted germline gene sequences, and some vaccine-induced antibodies exhibited higher binding affinities for hemagglutinins derived from prior years' seasonal influenza as compared to their affinities for the immunization strains. Our results show that influenza vaccination induces the recall of memory B cells that express antibodies that previously underwent affinity maturation against prior years' seasonal influenza, suggesting that 'original antigenic sin' shapes the antibody response to influenza vaccination.

[1]  George Georgiou,et al.  High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire , 2013, Nature Biotechnology.

[2]  Mark M. Davis,et al.  Plasmablast-derived polyclonal antibody response after influenza vaccination. , 2011, Journal of immunological methods.

[3]  K. Fink.  Origin and Function of Circulating Plasmablasts during Acute Viral Infections , 2012, Front. Immun..

[4]  Joaquín Dopazo,et al.  ETE: a python Environment for Tree Exploration , 2010, BMC Bioinformatics.

[5]  Patrice Duroux,et al.  IMGT/HIGHV-QUEST: THE IMGT® WEB PORTAL FOR IMMUNOGLOBULIN (IG) OR ANTIBODY AND T CELL RECEPTOR (TR) ANALYSIS FROM NGS HIGH THROUGHPUT AND DEEP SEQUENCING , 2012 .

[6]  Mark M. Davis,et al.  Limited efficacy of inactivated influenza vaccine in elderly individuals is associated with decreased production of vaccine-specific antibodies. , 2011, The Journal of clinical investigation.

[7]  Patrick C. Wilson,et al.  Rapid cloning of high-affinity human monoclonal antibodies against influenza virus , 2008, Nature.

[8]  K. Rajewsky,et al.  Somatic mutation and clonal expansion of B cells in an antigen‐driven immune response. , 1985, The EMBO journal.

[9]  J. Plotkin,et al.  Immune history shapes specificity of pandemic H1N1 influenza antibody responses , 2013, The Journal of experimental medicine.

[10]  N. Fischer,et al.  Sequencing antibody repertoires: the next generation. , 2011, mAbs.

[11]  Elissa K. Deenick,et al.  Intrinsic Differences in the Proliferation of Naive and Memory Human B Cells as a Mechanism for Enhanced Secondary Immune Responses1 , 2003, The Journal of Immunology.

[12]  R. Ahmed,et al.  Protective immunity and susceptibility to infectious diseases: lessons from the 1918 influenza pandemic , 2007, Nature Immunology.

[13]  R. Porcher,et al.  Detection of Extensive Cross-Neutralization between Pandemic and Seasonal A/H1N1 Influenza Viruses Using a Pseudotype Neutralization Assay , 2010, PloS one.

[14]  Pascale Mathonet,et al.  The Application of Next Generation Sequencing to the Understanding of Antibody Repertoires , 2013, Front. Immunol..

[15]  G. Nabel,et al.  Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination , 2010, Science.

[16]  W. Schmidt,et al.  CapSelect: a highly sensitive method for 5' CAP-dependent enrichment of full-length cDNA in PCR-mediated analysis of mRNAs. , 1999, Nucleic Acids Research.

[17]  J. Barry.  Pandemics: avoiding the mistakes of 1918 , 2009, Nature.

[18]  P. Wilson,et al.  Targeting B cell responses in universal influenza vaccine design. , 2011, Trends in immunology.

[19]  Seung Hyun Kang,et al.  Monoclonal antibodies isolated without screening by analyzing the variable-gene repertoire of plasma cells , 2010, Nature Biotechnology.

[20]  B. Pulendran,et al.  Rapid and Massive Virus-Specific Plasmablast Responses during Acute Dengue Virus Infection in Humans , 2012, Journal of Virology.

[21]  Mark Mulligan,et al.  Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells , 2012, Proceedings of the National Academy of Sciences.

[22]  Mark M. Davis,et al.  Lineage Structure of the Human Antibody Repertoire in Response to Influenza Vaccination , 2013, Science Translational Medicine.

[23]  O. Gascuel,et al.  New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0. , 2010, Systematic biology.

[24]  Sean A Beausoleil,et al.  A proteomics approach for the identification and cloning of monoclonal antibodies from serum , 2012, Nature Biotechnology.

[25]  J. Wrammert,et al.  Cross‐reactive humoral responses to influenza and their implications for a universal vaccine , 2013, Annals of the New York Academy of Sciences.

[26]  Kenneth G. C. Smith,et al.  Competence and competition: the challenge of becoming a long-lived plasma cell , 2006, Nature Reviews Immunology.

[27]  Stephen R. Quake,et al.  Genetic measurement of memory B-cell recall using antibody repertoire sequencing , 2013, Proceedings of the National Academy of Sciences.

[28]  Cécile Viboud,et al.  Antibody response to influenza vaccination in the elderly: a quantitative review. , 2006, Vaccine.

[29]  Robert C. Edgar,et al.  MUSCLE: multiple sequence alignment with high accuracy and high throughput. , 2004, Nucleic acids research.

[30]  L. Staudt,et al.  Generation of antibody diversity in the immune response of BALB/c mice to influenza virus hemagglutinin. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[31]  K. Subbarao,et al.  Heterovariant cross-reactive B-cell responses induced by the 2009 pandemic influenza virus A subtype H1N1 vaccine. , 2013, The Journal of infectious diseases.

[32]  A. Fauci,et al.  Insights into B cells and HIV‐specific B‐cell responses in HIV‐infected individuals , 2013, Immunological reviews.

[33]  C. Bridges,et al.  The annual impact of seasonal influenza in the US: measuring disease burden and costs. , 2007, Vaccine.

[34]  S. Tangye,et al.  Decreased expression of Krüppel-like factors in memory B cells induces the rapid response typical of secondary antibody responses , 2007, Proceedings of the National Academy of Sciences.

[35]  G. Nabel.  Designing tomorrow's vaccines. , 2013, The New England journal of medicine.

[36]  M. Nussenzweig,et al.  Dopamine in germinal centers , 2017, Nature Immunology.

[37]  Nicholas S. Kelley,et al.  Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. , 2012, The Lancet. Infectious diseases.